From Gene to LNP: Nucleic Acid Research and CDMO capabilities of WACKER

Tuesday, March 19, 2024 at 1:40 PM to 2:00 PM · 20 min. (Europe/London)
Innovation Showcase [Track 2]
Presentation
Wacker Chemie AG
27
WACKER BIOTECH is your partner of choice for process development and manufacturing of biopharmaceuticals (proteins, vaccines, live microbial products, plasmid DNA (pDNA)) using microbial hosts. Additionally, WACKER BIOTECH provides R&D and GMP manufacturing services for advanced therapies as a one-stop-shop: from the production of plasmid and template DNA as starting material for mRNA through the IVT of mRNA and LNP formulation. Our expertise ensures the best possible results for each of our client’s mRNA-focused projects. For more information, visit: wacker.com/biologics  

Documents & Links

  • From Gene to LNP: Nucleic Acid Research & CDMO Capabilities of WACKER

Registered attendees

Julius Mathews
Julius Mathews
Group ManagerFraunhofer Institute for Production Technology IPT
Karin Agerman
Karin Agerman
CSOCombiGene
Pedro Cejas
Pedro Cejas
Head of New Therapeutic ModalitiesSpark Therapeutics

Log in

See all the content and easy-to-use features by logging in or registering!